COPD exacerbations: definitions and classifications

被引:332
作者
Burge, S
Wedzicha, JA
机构
[1] Birmingham Heartlands Hosp, Birmingham B9 5SS, W Midlands, England
[2] St Bartholomews & Royal London Sch Med, Acad Unit Resp Med, London, England
关键词
chronic obstructive pulmonary; disease actiology; definition; exacerbation; incidence; prevention;
D O I
10.1183/09031936.03.00078002
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Chronic obstructive pulmonary disease (COPD) is defined independently of exacerbations, which are largely a feature of moderate-to-severe disease. This article is the result of a workshop that tried to define exacerbations of COPD for Use in clinical, pharmacological and epidemiological studies. The conclusions represent the consensus of those present. This review describes definitions, ascertainment, severity assessments, duration and frequency, using varying sources of data including direct patient interview, healthcare databases and symptom diaries kept by patients in studies. The best general definition of a COPD exacerbation is the following: an exacerbation of COPD is a sustained worsening of the patient's condition, from the stable state and beyond normal day-to-day variations that is acute in onset and may warrant additional treatment in a patient with underlying COPD. A more specific definition for studies where a bacteriological cause of exacerbation is being studied is included, as well as simpler definitions for retrospective identification from database sources. Prospective diary card assessments are best recorded as changes from an agreed baseline, rather than absolute symptom severities. Diary cards identify many unreported exacerbations, which on average have similar severities to reported exacerbations. A scale for exacerbation severity is proposed that incorporates in- and outpatient assessments. Exacerbation duration, which also relates to severity, is defined from diary card reports. Healthcare utilisation is not an adequate substitute for severity, depending on many unrelated social and comorbidity factors. It is an outcome in its own right.
引用
收藏
页码:46S / 53S
页数:8
相关论文
共 48 条
  • [11] DELAIGLESIA MF, 2000, ARCH BRONCHOPNEUMOL, V36, P84
  • [12] Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations
    Dentener, MA
    Creutzberg, EC
    Schols, AMWJ
    Mantovani, A
    van't Veer, C
    Buurman, WA
    Wouters, EFM
    [J]. THORAX, 2001, 56 (09) : 721 - 726
  • [13] Effect of temperature on lung function and symptoms in chronic obstructive pulmonary disease
    Donaldson, GC
    Seemungal, T
    Jeffries, DJ
    Wedzicha, JA
    [J]. EUROPEAN RESPIRATORY JOURNAL, 1999, 13 (04) : 844 - 849
  • [14] NATURAL-HISTORY OF CHRONIC AIR-FLOW OBSTRUCTION
    FLETCHER, C
    PETO, R
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1977, 1 (6077): : 1645 - 1648
  • [15] Patients hospitalized for COPD have a high prevalence of modifiable risk factors for exacerbation (EFRAM study)
    Garcia-Aymerich, J
    Barreiro, E
    Farrero, E
    Marrades, RM
    Morera, J
    Antó, JM
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2000, 16 (06) : 1037 - 1042
  • [16] Home treatment of exacerbations of chronic obstructive pulmonary disease by an acute respiratory assessment service
    Gravil, JH
    Al-Rawas, OA
    Cotton, MM
    Flanigan, U
    Irwin, A
    Stevenson, RD
    [J]. LANCET, 1998, 351 (9119) : 1853 - 1855
  • [17] Respiratory viral infections in adults with and without chronic obstructive pulmonary disease
    Greenberg, SB
    Allen, M
    Wilson, J
    Atmar, RL
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (01) : 167 - 173
  • [18] Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial
    Griffiths, TL
    Burr, ML
    Campbell, IA
    Lewis-Jenkins, V
    Mullins, J
    Shiels, K
    Turner-Lawlor, PJ
    Payne, N
    Newcombe, RG
    Lonescu, AA
    Thomas, J
    Tunbridge, J
    [J]. LANCET, 2000, 355 (9201) : 362 - 368
  • [19] An observational study of inhaled corticosteroid withdrawal in stable chronic obstructive pulmonary disease
    Jarad, NA
    Wedzicha, JA
    Burge, PS
    Calverley, PMA
    [J]. RESPIRATORY MEDICINE, 1999, 93 (03) : 161 - 166
  • [20] Lower respiratory illnesses promote FEV1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease -: Results from the Lung Health Study
    Kanner, RE
    Anthonisen, NR
    Connett, JE
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (03) : 358 - 364